Webinar: The Future of Clinical Trial Monitoring
Over 300 Clinical Studies Benefit from CluePoints’ COVID-19 Risk Management Support
New Paper: From RBM to RBQM – The Future of Risk-Based Trial Management
CluePoints & DIA Webinar: How is the Industry Coping with the Move to Remote Monitoring?
RBQM Doesn’t have to be Complicated, Risky or Expensive: Q&A
CluePoints Launches Powerful Business Intelligence Platform
New Webinar: Risk-Based Quality Management Doesn’t have to be Complicated, Risky or Expensive!
CluePoints Covid-19 Support Benefits Over 200 Clinical Studies Directly Affected by the Pandemic
Beyond COVID-19: The New Normal in Risk-Based Monitoring (RBM) and Quality Management (RBQM)
Find out where we’re headed next.
ICH E6 (R2)
Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.
ICH E6 (R2)
This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.